Ann Mari Rosager

Ann Mari Rosager

Auto-generated profile, based on publicly available information

Ann Mari Rosager

Department of Pathology, Odense University Hospital, Odense, Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAnn Mari Rosager
Ann Mari Rosager
MSMia Dahl Sørensen
Mia Dahl Sørensen
RDRikke H Dahlrot
Rikke H Dahlrot
SHSteinbjørn Hansen
Steinbjørn Hansen
DSDavid L Schonberg
David L Schonberg
BKBjarne W Kristensen
Bjarne W Kristensen
Astrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1) as well as ferritin heavy (FTH) and light (FTL) chain in astrocytic brain tumors. A cohort of 111 astrocytic brain tumors (grade II-IV) was stained immunohistochemically with antibodies against TfR1, FTH, and FTL and scored semi-quantitatively. Double-immunofluorescence stainings were established to determine the phenotype of cells expressing these markers. We found that TfR1, FTH, and FTL were expressed by tumor cells in all grades. TfR1 increased with grade (p<0.001), but was not associated with prognosis in the individual grades. FTH and FTL were expressed by tumor cells and cells with microglial/macrophage morphology. Neither FTH nor FTL increased with malignancy grade, but low FTH expression by both tumor cells (p = 0.03) and microglia/macrophages (p = 0.01) correlated with shorter survival in patients anaplastic astrocytoma. FTL-positive microglia/macrophages were frequent in glioblastomas, and high FTL levels correlated with shorter survival in the whole cohort (p = 0.01) and in patients with anaplastic astrocytoma (p = 0.02). Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. In conclusion, TfR1 was highly expressed in glioblastomas and associated with shorter survival in the whole cohort, but not in the individual malignancy grades. Low levels of FTH-positive tumor cells and microglia/macrophages were associated with poor survival in anaplastic astrocytomas, while high amounts of FTL-positive microglia/macrophages had a negative prognostic value. The results suggest that regulation of the iron metabolism in astrocytic brain tumors is complex involving both autocrine and paracrine signaling.

9 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RDRikke H. Dahlrot
Rikke H. Dahlrot
JBJulie A. Bangsø
Julie A. Bangsø
JPJeanette K. Petersen
Jeanette K. Petersen
ARAnn Mari Rosager
Ann Mari Rosager
MSMia Dahl Sørensen
Mia Dahl Sørensen
BKBjarne Winther Kristensen
Bjarne Winther Kristensen
Survival of glioblastoma patients varies and prognostic markers are important in the clinical setting. With digital pathology and improved immunohistochemical multiplexing becoming a part of daily diagnostics, we investigated the prognostic value of the Ki-67 labelling index (LI) in glioblastomas more precisely than previously by excluding proliferation in non-tumor cells from the analysis. We investigated the Ki-67 LI in a well-annotated population-based glioblastoma patient cohort (178 IDH-wildtype, 3 IDH-mutated). Ki-67 was identified in full tumor sections with automated digital image analysis and the contribution from non-tumor cells was excluded using quantitative double-immunohistochemistry. For comparison of the Ki-67 LI between WHO grades (II-IV), 9 IDH-mutated diffuse astrocytomas and 9 IDH-mutated anaplastic astrocytomas were stained. Median Ki-67 LI increased with increasing WHO grade (median 2.7%, 6.4% and 27.5%). There was no difference in median Ki-67 LI between IDH-mutated and IDH-wildtype glioblastomas (p = 0.9) and Ki-67 LI was not associated with survival in glioblastomas in neither univariate (p = 0.9) nor multivariate analysis including MGMT promoter methylation status and excluding IDH-mutated glioblastomas (p = 0.2). Ki-67 may be of value in the differential diagnostic setting, but it must not be over-interpreted in the clinico-pathological context.

25 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SJStine Skov Jensen
Stine Skov Jensen
Morten MeyerMorten Meyer
Morten Meyer
SPStine Asferg Petterson
Stine Asferg Petterson
BHBo Halle
Bo Halle
ARAnn Mari Rosager
Ann Mari Rosager
BKBjarne Winther Kristensen
Bjarne Winther Kristensen
Glioblastoma is the most frequent and malignant brain tumor. Recurrence is inevitable and most likely connected to tumor invasion and presence of therapy resistant stem-like tumor cells. The aim was therefore to establish and characterize a three-dimensional in vivo-like in vitro model taking invasion and tumor stemness into account. Glioblastoma stem cell-like containing spheroid (GSS) cultures derived from three different patients were established and characterized. The spheroids were implanted in vitro into rat brain slice cultures grown in stem cell medium and in vivo into brains of immuno-compromised mice. Invasion was followed in the slice cultures by confocal time-lapse microscopy. Using immunohistochemistry, we compared tumor cell invasion as well as expression of proliferation and stem cell markers between the models. We observed a pronounced invasion into brain slice cultures both by confocal time-lapse microscopy and immunohistochemistry. This invasion closely resembled the invasion in vivo. The Ki-67 proliferation indexes in spheroids implanted into brain slices were lower than in free-floating spheroids. The expression of stem cell markers varied between free-floating spheroids, spheroids implanted into brain slices and tumors in vivo. The established invasion model kept in stem cell medium closely mimics tumor cell invasion into the brain in vivo preserving also to some extent the expression of stem cell markers. The model is feasible and robust and we suggest the model as an in vivo-like model with a great potential in glioma studies and drug discovery.

7 December 2021 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
ARAnn Mari Rosager
Ann Mari Rosager
RDRikke H Dahlrot
Rikke H Dahlrot
MSMia D Sørensen
Mia D Sørensen
JBJulie A Bangsø
Julie A Bangsø
SHSteinbjørn Hansen
Steinbjørn Hansen
BKBjarne W Kristensen
Bjarne W Kristensen
Patients with IDH-wildtype glioblastoma (GBM) generally have a poor prognosis. However, there is an increasing need of novel robust biomarkers in the daily clinico-pathological setting to identify and support treatment in patients who become long-time survivors. Jumonji domain-containing protein 6 (JMJD6) is involved in epigenetic regulation of demethylation of histones and has been associated with GBM aggressiveness. We investigated the expression and prognostic potential of JMJD6 tumor fraction score in 184 IDH-wildtype GBMs. Whole-slides were double-stained with an antibody against JMJD6 and an exclusion-cocktail consisting of 4 antibodies (CD31, SMA, CD45, and Iba-1), enabling evaluation of tumor cells only. Stainings were quantified with a combined software- and scoring-based approach. For comparison, IDH-mutated WHO grade II, III and IV astrocytic gliomas were also stained, and the JMJD6 tumor fraction score increased with increasing WHO grade, although not significantly. In multivariate analysis including age, gender, performance status and post-surgical treatment high JMJD6 tumor fraction score was associated with longer overall survival in IDH-wildtype GBMs (p = 0.03), but the effect disappeared when MGMT promoter status was included (p = 0.34). We conclude that JMJD6 is highly expressed in IDH-wildtype GBM but it has no independent prognostic value.

4 May 2024 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MJMikkel Bak Jensen
Mikkel Bak Jensen
ARAnn Mari Rosager
Ann Mari Rosager
MSMathias Tiedemann Svendsen
Mathias Tiedemann Svendsen
We present the clinical case of a 39-year-old woman diagnosed with acquired trichorrhexis nodosa (TN). This hair condition is characterized by irregular nodular formations along the hair shaft, leading to fragility and breakage. This case is notable for its association with pregnancy, expanding the understanding of the aetiology of TN beyond the traditionally recognized chemical and physical causes. The study emphasizes the psychosocial impact of hair shaft abnormalities and the importance of accurate diagnosis and compassionate patient care.

1 October 2026 in Psoriasis: Targets and Therapy
Verified
Journal Article
Open access
PDF file
MNMarielle Nyheim-Tømmerås
Marielle Nyheim-Tømmerås
BKBjørn Kromann
Bjørn Kromann
LMLine Bruun Pilgaard Møller
Line Bruun Pilgaard Møller
ARAnn Mari Rosager
Ann Mari Rosager
MBMichael Bzorek
Michael Bzorek
BDBeatrice Dyring-Andersen
Beatrice Dyring-Andersen
Increased free cholesterol and cholesterol synthesis proteins in the epidermis of psoriasis lesions.